2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Circulation
JANUARY 27, 2025
Circulation, Ahead of Print.
How much do you know about PAD (Peripheral Artery Disease)?
CTVS
MAY 29, 2024
Nearly 10 million Americans suffer from the circulatory condition Peripheral Artery Disease, or PAD. PAD occurs when plaque builds up in the arteries and limits blood flow to the lower extremities.
Galectin-3 and peripheral artery disease: a Mendelian randomization study
Frontiers in Cardiovascular Medicine
JANUARY 3, 2024
Background Multiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). Conclusions There is no current evidence to establish a causal relationship between the level of Gal-3 in circulation and PAD.
How to Prevent Peripheral Artery Disease
AMS Cardiology
NOVEMBER 4, 2023
However, when these arteries become narrowed or blocked conditions like Peripheral Artery Disease (PAD) can emerge, posing a threat to our overall health. Understanding Peripheral Artery Disease Peripheral artery disease or PAD is a condition in which plaque builds up in the arteries that lead to the legs and feet.
New PAD Guidelines; AHA on Postpartum Care; Exercise Didn't Stop CAC Progression
Med Page Today
MAY 21, 2024
(MedPage Today) -- Low-dose rivaroxaban (Xarelto), SGLT2 inhibitors, and GLP-1 receptor agonists have entered multisocietal guidelines on peripheral artery disease (PAD) for the first time. Circulation) Recommendations for postpartum care were.
Blood platelet score detects previously unmeasured risk of heart attack and stroke
Medical Xpress - Cardiology
AUGUST 20, 2024
Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels.
Heart Attack 
102
102 
Peripheral Artery Disease: Past and Future
Circulation
APRIL 7, 2024
Circulation, Volume 149, Issue 15 , Page 1151-1153, April 9, 2024.
CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association
Circulation
JUNE 20, 2024
Circulation, Ahead of Print. There is significant variability in the efficacy and safety of oral P2Y12 inhibitors, which are used to prevent ischemic outcomes in common diseases such as coronary and peripheral arterial disease and stroke.
Understanding the Pain Experience and Treatment Considerations Along the Spectrum of Peripheral Artery Disease: A Scientific Statement From the American Heart Association
Circulation: Cardiovascular Quality & Outcomes
FEBRUARY 10, 2025
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Peripheral artery disease (PAD) is an atherosclerotic condition that affects a growing number of individuals worldwide, with estimates exceeding 220 million.
Abstract 4147504: Efficacy and Safety of Vorapaxar in Patients with Peripheral Arterial Disease: A Meta-Analysis of Randomized Controlled Trials
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4147504-A4147504, November 12, 2024. There are discrepancies in the literature regarding whether vorapaxar alleviates ischemic outcomes and increases bleeding in patients with peripheral arterial disease (PAD).Purpose:The
PAD Awareness Month and Treating Arterial Ulcers
CTVS
SEPTEMBER 17, 2024
It is estimated that more than 10 million Americans are living with PAD, or Peripheral Artery Disease. PAD is a serious condition affecting circulation and blood vessels, causing them to narrow from plaque buildup in the arteries and blocking blood flow to the extremities, typically the legs and feet.
Overcoming Challenges to Implementing New Evidence for Low-Dose Anticoagulant Use in Peripheral Artery Disease
Circulation
DECEMBER 10, 2023
Circulation, Volume 148, Issue 24 , Page 1929-1931, December 12, 2023.
Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Circulation
APRIL 6, 2025
Circulation, Volume 151, Issue 14 , Page e918-e918, April 8, 2025.
Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association
Circulation
DECEMBER 14, 2023
Circulation, Ahead of Print. Despite the known higher risk of cardiovascular disease in individuals with type 2 diabetes, the pathophysiology and optimal management of diabetic foot ulcers (DFUs), a leading complication associated with diabetes, is complex and continues to evolve.
Diabetes 76
76 Abstract 4136687: VTRNA2-1 Promoter Methylation as a Prognostic Biomarker in Peripheral Artery Disease: Implications for Maternal Nutritional Influence
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4136687-A4136687, November 12, 2024. Background:Peripheral artery disease (PAD) is associated with high morbidity and mortality and is closely related to diabetes mellitus (DM) and atherosclerosis.
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Circulation
JANUARY 24, 2024
Circulation, Ahead of Print.
Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs
DAIC
JANUARY 18, 2024
(Photo: Business Wire milla1cf Thu, 01/18/2024 - 14:05 January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse Injectable balloon catheter platform.
Angioplasty 105
105 Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis
Circulation
DECEMBER 28, 2023
Circulation, Ahead of Print. Using mediation Mendelian randomization, we explored proteomic mediators of the effects of genetically proxied IL-6 signaling on coronary artery disease, large artery atherosclerotic stroke, and peripheral artery disease.
Introduction
The British Journal of Cardiology
AUGUST 1, 2024
1 It is associated with an increased risk of atherosclerotic cardiovascular disease, stroke and peripheral arterial disease, independent of traditional cardiovascular risk factors.
Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry
Circulation: Cardiovascular Quality & Outcomes
FEBRUARY 6, 2024
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Patients who had an myocardial infarction, underwent coronary artery bypass graft (hazard ratio, 1.60 [95% CI, 1.55–1.65]),
Abstract 4139108: Identifying Predictors of Durable Treatment Response among Patients with Claudication; A Secondary Analysis of the CLEVER Trial
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4139108-A4139108, November 12, 2024. Background:Symptomatic peripheral artery disease (PAD) is prevalent and targeted therapies include optimal medical care (OMC), supervised exercise therapy (SET) and revascularization (ST).
Abstract 114: “Failing” DAPT? Think Again
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Contralateral vertebral artery stenosis, which is unable to supply retrograde flow during compression, is the likely etiology of this patient's strokes. Recurrent posterior circulation strokes in the setting of optimal medical management should clue clinicians to consider other etiologies of stroke.
Stenosis 40
40 
New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies
DAIC
MAY 16, 2024
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
New Dodero Center at UH will Revolutionize Limb Salvage
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD
Circulation
OCTOBER 18, 2023
Circulation, Volume 148, Issue 24 , Page 1919-1928, December 12, 2023. The effect has not been described in patients undergoing endovascular LER.METHODS:The VOYAGER PAD trial randomized 6564 patients with symptomatic peripheral artery disease to a double-blinded treatment with 2.5
HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients
DAIC
MAY 8, 2024
The 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).” Circulation, vol. “Diagnosis and treatment of ischemia-producing coronary stenoses improves 5-year survival of patients undergoing major vascular surgery.”
American Heart Month Puts Spotlight on Cardiovascular Disease and Stroke Statistics
DAIC
FEBRUARY 1, 2024
Each year, the American Heart Association (AHA) gathers a Statistical Update, described as a major source for monitoring cardiovascular health, risk factors and disease in the United States and global population, and published annually in the AHA flagship journal Circulation.
University Hospitals Receives Grant for New Limb Preservation Center
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.
Hospital 52
52 Society for Vascular Surgery Launches Campaign to Help People Maintain Vascular Health
DAIC
OCTOBER 23, 2024
According to a recent survey released today by the Society, nearly one in three Americans at the highest risk for developing blood vessel (vascular) diseases have not heard of any of the most common conditions, like peripheral artery disease and carotid artery disease.
Abstract 136: Infarct Topography, Effect of Anticoagulation, and Recurrence after Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
Stroke Journal
JANUARY 30, 2025
Models were adjusted for age, sex, race, ethnicity, heart failure, coronary artery disease, peripheral artery disease, hypertension, diabetes, and tobacco use. Cox models were used to compare stroke recurrence in patients with multi-territory versus single-territory infarction.
Stroke 40
40 
Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk
DAIC
JANUARY 23, 2024
Inflammation driven by signaling cytokines, circulating immune cells, adhesion molecules, and oxidized low-density lipoprotein cholesterol (LDL-C) leads to atherosclerotic plaque development, plaque progression, and eventual rupture.14,15 2019 Sep 10;140(11):e649-e650] [published correction appears in Circulation. Circulation.
Advanced Vascular Care
AMS Cardiology
MARCH 20, 2025
Common Vascular Conditions We Treat Some vascular diseases affect your arteries while others occur in your veins. Atherosclerosis & Arterial Diseases Peripheral Artery Disease (PAD) : A blockage in your legs. Total loss of circulation can lead to gangrene and loss of a limb.
Let's personalize your content